Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Gaviscon Advance oral susp peppermint (Reckitt Benckiser)
0101021B0BEBEAL
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 177,286 |
|
Peptac liquid peppermint
0101021B0BIABAH
|
Peptac | Alginic acid compound preparations | Gastro-Intestinal System | 171,508 |
|
Gaviscon Advance oral suspension aniseed (Reckitt Benckiser)
0101021B0BEAIAL
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 126,592 |
|
Peptac liquid aniseed
0101021B0BIAAAH
|
Peptac | Alginic acid compound preparations | Gastro-Intestinal System | 120,061 |
|
Sodium algin 500mg/Potassium bicarb 100mg/5ml susp SF
0101021B0AAALAL
|
Alginic acid compound preparation | Alginic acid compound preparations | Gastro-Intestinal System | 90,088 |
|
Gaviscon Infant oral powder sachets
0101021B0BEADAJ
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 66,395 |
|
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser)
0101021B0BEAQAP
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 43,633 |
|
Acidex Advance oral suspension peppermint
0101021B0BQADAL
|
Acidex (Alginic acid) | Alginic acid compound preparations | Gastro-Intestinal System | 34,796 |
|
Alginate raft-forming oral suspension sugar free
0101021B0AAAHAH
|
Alginic acid compound preparation | Alginic acid compound preparations | Gastro-Intestinal System | 30,043 |
|
Acidex Advance oral suspension aniseed
0101021B0BQACAL
|
Acidex (Alginic acid) | Alginic acid compound preparations | Gastro-Intestinal System | 23,171 |
|
Gaviscon Original Aniseed Relief
0101021B0BEACAH
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 16,535 |
|
Sodium algin 500mg/Potassium bicarb 100mg chew tab SF
0101021B0AAAPAP
|
Alginic acid compound preparation | Alginic acid compound preparations | Gastro-Intestinal System | 14,768 |
|
Gaviscon Peppermint Liquid Relief
0101021B0BEAFAH
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 13,415 |
|
Gaviscon Double Action chewable tablets mint
0101021B0BEARA0
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 10,201 |
|
Gaviscon Double Action Liquid peppermint
0101021B0BEASA0
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 8,403 |
|
Acidex oral suspension peppermint
0101021B0BQABAH
|
Acidex (Alginic acid) | Alginic acid compound preparations | Gastro-Intestinal System | 4,730 |
|
Acidex oral suspension aniseed
0101021B0BQAAAH
|
Acidex (Alginic acid) | Alginic acid compound preparations | Gastro-Intestinal System | 3,407 |
|
Gaviscon Peppermint chewable tablets
0101021B0BEAUAR
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 3,268 |
|
Gaviscon Double Action Liquid aniseed
0101021B0BEAVA0
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 3,182 |
|
Gaviscon Double Action chewable tablets mixed berries
0101021B0BEBFA0
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 666 |
|
Gaviscon Double Action Liquid 10ml sachets
0101021B0BEBDA0
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 547 |
|
Sod algin 225mg/Mag algin 87.5mg/dose oral pdr sach SF
0101021B0AAAJAJ
|
Alginic acid compound preparation | Alginic acid compound preparations | Gastro-Intestinal System | 293 |
|
Gaviscon Strawberry chewable tablets
0101021B0BEAWAR
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 216 |
|
Gaviscon Liquid 10ml sachets
0101021B0BEAJAM
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 195 |
|
Gaviscon Cool Liquid
0101021B0BEANAH
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 16 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.